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Abstract
Introduction: Observational studies have shown considerable attrition among adolescents living with HIV across the
“cascade” of HIV care in sub-Saharan Africa, leading to higher mortality rates compared to HIV-infected adults or children.
We synthesized evidence from qualitative studies on factors that promote or undermine engagement with HIV services
among adolescents living with HIV in sub-Saharan Africa.
Methods: We systematically searched five databases for studies published between 2005 and 2016 that met pre-defined
inclusion criteria. We used a meta-ethnographic approach to identify first, second and third order constructs from eligible
studies, and applied a socio-ecological framework to situate our results across different levels of influence, and in relation to
each stage of the HIV cascade.
Results and discussion: We identified 3089 citations, of which 24 articles were eligible for inclusion. Of these, 17 were from
Southern Africa while 11 were from Eastern Africa. 6 explored issues related to HIV testing, 11 explored treatment adherence,
and 7 covered multiple stages of the cascade. Twelve third-order constructs emerged to explain adolescents’ engagement in HIV
care. Stigma was the most salient factor impeding adolescents’ interactions with HIV care over the past decade. Self-efficacy to
adapt to life with HIV and support from family or social networks were critical enablers supporting uptake and retention in HIV
care and treatment programmes. Provision of adolescent-friendly services and health systems issues, such as the availability of
efficient, confidential and comfortable services, were also reported to drive sustained care engagement. Individual-level factors,
including past illness experiences, identifying mechanisms to manage pill-taking in social situations, financial (in)stability and the
presence/absence of future aspirations also shaped adolescents HIV care engagement.
Conclusions: Adolescents’ initial and ongoing use of HIV care was frequently undermined by individual-level issues; although
family, community and health systems factors played important roles. Interventions should prioritise addressing psychosocial
issues among adolescents to promote individual-level engagement with HIV care, and ultimately reduce mortality. Further
research should explore issues relating to care linkage and ART initiation in different settings, particularly as “test and treat”
policies are scaled up.
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Introduction
Globally, it has been estimated that approximately 2.1 mil-
lion adolescents aged 10–19 years are living with HIV, with
nearly 85% of this population residing in sub-Saharan Africa
(SSA) [1]. Whilst initiatives to improve access to antiretro-
viral therapy (ART) in low- and middle-income countries
(LMIC) contributed to a 30% decline in AIDS-related mor-
tality between 2005 and 2012 [2], adolescents have been
left behind. In the same time-period, AIDS-related mortality
amongst adolescents increased by 50%, with over 90% of
these deaths occurring in SSA [1].
The clustering of adolescent AIDS-related mortality in
SSA is largely attributable to an approximate 10-year
time-lapse in ART interventions compared to high-income
nations [3]. Many of the children perinatally infected in
SSA, while prevention of mother-to-child transmission
(PMTCT) programme coverage was still low, are now reach-
ing their adolescence [4,5]. However, less than 30% of
adolescent girls and 10% of adolescent boys aged
15–19 years in SSA report ever having undergone an HIV
test [6]. In addition, the regional adolescent population has
been projected to double by 2050, with adolescents making
up approximately 46% of the total population [6].
Recent global initiatives have called for adolescent health
to be prioritized as young people represent a “triple divi-
dend” investment – of benefit now, to the next generation
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of adults and to the health of generations to come [7]. At
the heart of these initiatives lies the need to prevent and
treat infections among this population, making care and
treatment for ALHIV a policy priority for many African
governments. This places new pressures on health systems
and services to meet the needs of a rapidly expanding
generation of both diagnosed and undiagnosed adolescents
living with HIV (ALHIV) [5,8].
Transition from childhood into adulthood is characterized
by rapid physical, mental and sexual development, and in
addition to this, ALHIV have complex emotional, psycholo-
gical and health-related requirements that need to be
reconciled to effectively manage their lives with HIV [4].
In SSA, the majority of ALHIV under 14 years of age have
been infected perinatally [9] and many are orphaned by
one or both parents [10] forcing them into early emotional
maturity and adult responsibilities. Furthermore, while
some have been on ART since a very young age, others
have been living with the virus untreated for over a decade.
Without access to ART, those untreated are not expected to
survive beyond their teenage years [9]. For those that do
survive, great efforts are needed to increase care access
and improve retention on ART to reduce AIDS-related mor-
tality and onward horizontal transmission of HIV [9].
Quantitative research indicates that in many settings
ALHIV experience higher rates of loss to follow-up and
virological failure than both adults and children living with
HIV [11–14]. Geographically discreet qualitative studies in
different countries in SSA suggest that stigma, challenges in
disclosure and consent policies for testing and treatment
are reasons for faltering ALHIV care engagement, however,
there has been no published synthesis of these studies.
Meta-ethnographic methods enable an in-depth assess-
ment of various health-related research topics [15,16],
including factors that influence patient care experiences
and medication adherence in LMIC [17,18]. Meta-ethnogra-
phy aims to expand upon, or develop new interpretations
of qualitative data. The “constant comparison” approach is
used to determine if themes across varying contexts are
reciprocal (complementary concepts) or refutational (con-
tradictory concepts), supporting further hypothesis devel-
opment [17,19–21]. Our meta-ethnography includes
qualitative studies undertaken across the region, in order
to understand the most influential issues affecting adoles-
cent initiation of, and retention in, HIV care in SSA. Our
synthesis of 10 years of qualitative research conducted
since the advent of ART expansion enables a longitudinal
line of inquiry, allowing us to assess changes across time, in
different countries in SSA and across all stages of the HIV
care cascade.
Theoretical frameworks
The HIV care cascade describes progression through HIV
diagnosis, care and treatment services and is commonly
defined in five stages: (i) HIV diagnosis, (ii) linkage to
care, (iii) engagement/retention in care, (iv) ART initiation
and (v) viral suppression [22, 23]. The cascade has been
widely used as a framework to explore reasons for patient
attrition between these five stages, with some variations in
the definitions for each stage depending on the study
design or nature of the data that are available. For exam-
ple, in relation to stage v, qualitative studies often explore
patients’ experiences of adherence to antiretroviral ther-
apy, rather than investigating viral suppression per se,
which is more commonly measured in studies with a quan-
titative design [24,25].
For adolescents, traversing the cascade is complicated
by the lack of autonomy in care-seeking that charac-
terizes this age-group, including the requirement for guar-
dian accompaniment to access services. Further
disruptions in HIV care among adolescents have been
noted to occur during the transition from paediatric into
adult care [26] or as they transition in and out of PMTCT
programmes [27,28]. Such challenges perpetuate the risk
of attrition and associated mortality [26,29].
“Engagement” with the HIV care cascade involves the
willingness and ability of ALHIV to undergo HIV testing,
initiate treatment, adhere to ART and negotiate the lin-
kages between different HIV services and models of care
(e.g. paediatric and adult; pre-ART and ART). This engage-
ment with HIV care and treatment is influenced by a
multitude of factors including basic service access, eco-
nomic capability, and awareness of their HIV status [30].
The socio-ecological model (SEM) has been frequently
used across HIV literature to illustrate the range of social
influences on health behaviours, including care fallout
[31,32]. The SEM is particularly useful in exploring health
decisions made by individuals in LMIC or communities with
high levels of disease stigmatization [33–35]. The model
illustrates four levels of influence on health decisions
(Figure 1): i) structural factors, such as health systems,
policies and underlying poverty; ii) community factors,
including social norms around treatment-seeking and
beliefs surrounding disease aetiology; iii) family and peer
influences, including expectations of behaviours within
these social contexts; iv) and individual factors at the mod-
el’s core, including knowledge, perceptions, self-efficacy
and risks associated with care-seeking. Influential factors
may act across more than one level of the SEM: for exam-
ple, family influences on adolescents’ care-seeking beha-
viours may be affected by structural factors such as
economic circumstances of the household or consent poli-
cies that limit access to services.
Methods
Search strategy
For each search, five essential concepts were identified:
HIV, adolescents, SSA, barriers /facilitators and each of
the five stages of the care cascade. All possible search
terms and synonyms for each concept were established
and multiple spellings were incorporated. We searched
five databases known for having a high volume of social
and health-related research or articles specific to adoles-
cents: PubMed, Web of Science, Scopus, Global Health and
ADOLEC. Titles and abstracts of identified literature were
imported into EndNote and reviewed to eliminate dupli-
cates. References from highly relevant articles and
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systematic reviews were further checked for additional
eligible articles.
Inclusion /exclusion criteria
Studies were included if they involved qualitative or mixed
methods, were published between January 2005 and March
2016, included an adolescent population in the age range
10–19 years (if the study included children, young adults or
adults, it was included so long as the adolescent population
was distinct in the results), were conducted in one or more
countries within SSA (or included a defined population in
SSA) and stated aims that included an assessment of factors
influencing adolescent engagement with at least one stage
of the HIV care cascade. Only articles published in English
were included.
Quality appraisal
The importance of appraising the quality of health research
is increasingly recognized, although challenges include the
lack of a standardized method or approach [36,37]. The
Oxford Critical Appraisal Skills Programme (CASP) criteria
is one of the most widely used checklists for qualitative
research, enabling an assessment to be made of a study’s
validity, rigour and relevance [38].
Two researchers (SW, LG) reviewed all articles according
to the ten-point scale proposed by CASP and scored them
independently. One point was given for each checklist cri-
terion present in the research article and zero points were
given for absent criterion. Individual scores were compared
and differences deliberated until an agreement was
reached. Any scoring not reached in agreement was sub-
mitted to a third researcher (AW) for final review.
Thematic analysis
Thematic constructs were noted according to the methods
of conducting meta-ethnographic analysis suggested by
Noblit and Hare [19] and findings were applied to the
SEM. In each article, first-order constructs were identified
through study participant quotations in the text. Second-
order constructs were then distinguished from these based
on the researchers’ perspectives, mainly presented in the
discussion sections of research articles. Comparison of first
and second order constructs was examined chronologically
across studies that explored the same stage of HIV care.
Articles that covered more than one stage of care were
catalogued into each stage of the cascade sequentially, for
a complete analysis of themes specific to that stage. Third
order constructs were then defined to contextualize all
identified themes across the entire cascade of care, noting
reciprocal and highly salient constructs.
Results
Characteristics of included studies
In total, 3089 publications were identified through the
search. Following the review of titles and abstracts, 2974
Structural
Community
Family / Peer
Individual
Guardian 
consent 
policies
Privacy / 
confidentiality 
of services Disclosure
HIV 
myths
External 
stigma
Financial 
stability
Resilience
Distance to clinic Health 
worker 
shortages
Self-efficacy
Early parental loss
Education
Internal stigma
Figure 1. The four levels of the socio-ecological model that have the potential to affect health behaviours, with examples of factors that
operate at each level.
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were excluded for not meeting the inclusion criteria, most
of which were quantitative studies. The remaining 115
articles were reviewed in full, following which an additional
92 were excluded (the majority for lacking results specific
to adolescents). 1 additional relevant study was discovered
searching article references. In total, 24 qualitative and
mixed methods articles were selected for inclusion in the
meta-ethnography (Figure 2).
The eligible articles were catalogued in accordance to
HIV care cascade stages (i.e. HIV diagnosis, linkage to
care, engagement/retention in pre-ART care, ART initiation
and adherence), and within those stages arranged chron-
ologically by year of research. Table 1 presents the char-
acteristics of included studies.
The majority of identified studies were conducted in
Southern and Eastern Africa with notable gaps in some
high prevalence countries, including Mozambique,
Swaziland and Lesotho (Figure 3).
Out of the 24 studies included in our review, 6 explored
issues related to cascade stage one, HIV testing, and 11
Exclusions based on title and abstract:
1. Quantitative: n = 2618
2. Not adolescent specific: n = 313
3. Unrelated to care cascade: n = 18
4. Unrelated to barriers / facilitators: 1
5. Not in sub-Saharan Africa: n = 24
Total screened 
(title & abstract)
n = 3089
Articles reviewed 
in detail
n = 115
Exclusions based on full text review:
1. Quantitative: n = 2
2. Not adolescent specific:  n = 28
3. Unrelated to care cascade: n = 8
Total articles 
included in review
n = 24
Format exclusions:
Editorial / Topic 
discussion / Literature 
review / Conference 
proceedings
(References searched) 
n = 54
Web of 
Science
references:
n = 2292
Duplicates 
removed:
n = 2786
PubMed
references:
n = 1721
Scopus
references:
n = 1416
Global Health
references:
n = 389
Adolec
references:
n = 57
Found in 
references
n=1
Figure 2. Flow diagram showing search strategy and number of articles identified at each stage.
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Table 1. Characteristics of included qualitative and mixed methods studies
# Care stage(s)
1st author,
year
Year of
research Location Setting
Age range of
adolescents Data collection method Aims
1 1 Rassjo, 2007 2004 Uganda Urban slums; Kampala 10–21a FGD and IDI: adolescents &
young adults.
To evaluate young people’s perceptions
regarding VCT and the barriers and
facilitators to testing.
2 1 Izugbara, 2009 2004 Uganda,
Malawi
Urban and rural 14–19 FGD: adolescent males To offer youth perspectives on VCT; specifically,
how young men navigate their identities and
masculinity as they relate with HIV services.
3 1 Ferrand, 2011 2009 Zimbabwe Clinics; urban suburbs,
Harare
10–18 IDI: adolescents and
guardians.b
To investigate adolescent & guardian
acceptability and rate of service uptake of
PITC, as well as risk perceptions of MTCT.
4 1 Francis, 2010 2009 South Africa Industrial zones; Shongweni,
Durban
16–19 IDI: out-of-school youth. To collect out-of-school/working youth
perceptions on VCT and survey knowledge
about HIV using peer researchers.
5 1 Ntsepe, 2014 2011 South Africa Urban community venues &
schools: Cape Town,
Durban
12-adult a FGD: adolescents, young
people & adults.
To evaluate differences in perception,
acceptability and uptake of HTC in different
racial communities in South Africa.
6 1 Strauss, 2015 2012–2013 South Africa Rural schools: Vulindlela,
KwaZulu-Natal
>16 secondary
school
students
FGD: in-school adolescents. To examine barriers and facilitators to HCT uptake
offered to young people in school settings.
7 5 Schenk, 2014 2007 Kenya Areas within 5 km of
paediatric HIV clinics in
Narobi, Eastern & Nyanza
provinces
<15 a IDI: Caregivers, HCW, clinic
managers & MoH reps.
To define demand side barriers to uptake of
HIV services for perinatally infected children
<15, with an elaboration on the challenges
specific to adolescents.
8 5 Mavhu, 2013 2009 Zimbabwe Africaid community support
groups – Harare (urban)
15–18 FGD & IDI: ALHIV, caregivers,
HCW. Life narratives:
ALHIV.b
To strengthen the evidence base for a
psychosocial intervention planned by
Africaid for ALHIV utilizing community spaces
to host peer support groups.
9 5 Lowenthal,
2014
2009–2010 Botswana Clinics: Gaborone (urban) 10–19 IDI: ALHIV To identify the culturally specific factors necessary
to adapt in order to best utilizewestern tools for
psychosocial assessment when exploring
correlates of adherence for ALHIV in SSA.
10 5 Li, 2010 2010 South Africa Urban clinic: Cape Town 10–15 FGD: ALHIV To identify experiences, needs and illness
perspectives of both behaviourally and
perinatally infected ALHIV.
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Table 1. (Continued)
# Care stage(s)
1st author,
year
Year of
research Location Setting
Age range of
adolescents Data collection method Aims
11 5 Denison, 2015 2011–2012 Zambia Two ART clinics (1 children’s,
1 general) – Ndola (urban)
15–18 IDI: ALHIV and caregivers. To explore ART adherence from the
perspective and experiences of older
adolescents (15–18) and their caregivers.
12 5 Nyogea, 2015 2011–2012 Tanzania Chronic disease clinic –
Ifakara (rural)
13–17
Qualitative
(equal
component)
FGD, IDI: ALHIV &
caregivers.b
To estimate adherence levels and find the
determinants of ART adherence for children
and adolescents.
13 5 Vreeman,
2012
2012 Kenya AMPATH clinics: urban &
rural
10–18 IDI: adolescents &
caregivers. Cognitive
interviewing: ALHIV.
To improve understandability of paediatric ARV
adherence measurement items used in
resource limited settings through cognitive
interviewing.
14 5 Mutumba,
2015
2012 Uganda Urban clinics 13–19 IDI: ALHIV To identify the psychosocial challenges and coping
strategies of perinatally infected ALHIV.
15 5 Mupambireyi,
2014
2011–2013 Zimbabwe Low income, suburbs 11–13 FGD & IDI: adolescents &
caregivers.b
To explore peer social support experiences of
young, perinatally infected adolescents.
16 5 Bernays, 2015 2011–2013 Uganda,
Zimbabwe
Clinics: Multi-site, recruited
from ARROW Trial
11–13 IDI: ALHIV To examine experiences of living with HIV on
ART from the perspective of young ALHIV,
carers and HCWs.
17 5 Cluver, 2015 2013 South Africa Clinics: Eastern Cape, low
resource province
10–19 IDI: ALHIV. FGD: adolescents,
caregivers & parents.b
To examine associations between knowledge of
HIV+ status (disclosure) and ART adherence.
18 2, 5 Kunapareddy,
2014
2007 Kenya AMPATH clinics: urban &
rural
10–16 FGD & IDI: ALHIV To identify key factors related to medication
adherence for perinatally infected ALHIV on
ART culturally specific to SSA.
19 2, 5 Mattes, 2014 2008–2011 Tanzania Orphanages and private
homes – Tanga
9–19 a IDI: ALHIV & caregivers.
Observation: ALHIV. Photo
elicitation: ALHIV.
To compare national guidelines for HIV
disclosure and treatment management with
the lived realities of ALHIV.
20 2,3 Petersen,
2010
2010 South Africa Hospital – Durban (rural) 14–16 IDI: ALHIV and caregivers. To develop an understanding of psycho-social
challenges and protective influences
promoting socio-emotional coping; to inform
mental health promotion and HIV prevention
programmes.
21 2, 5 Hodgson,
2012
2010 Zambia Clinics: 1 Kalomo province
(rural); 2 Lusaka & Kitwe
province (urban)
10–19 IDI & FGD: adolescents,
parents & guardians.
To explore and document the educational,
psychosocial and SRH needs of ALHIV.
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explored factors related to stage five, ART adherence. The
remaining 7 studies examined multiple stages of the cas-
cade. No qualitative studies were identified that specifically
aimed to explore factors influencing ALHIV linkage to care
following diagnosis (stage 2), engagement/retention in gen-
eral medical care (stage 3) or initiation onto ART (stage 4).
Quality assessment
Eighteen out of 24 (75%) of the included studies were rated
moderate to high quality, scoring 7–10 points on the CASP
scale; and none of the studies scored below six points. The
CASP criteria least achieved (absent in 13 out of 24 articles
(54%)) was a failure to elaborate on the relationship
between researchers and study participants (CASP cri-
teria 6).
Themes influencing the engagement of ALHIV in care and
treatment services
Twelve third-order themes were identified, many of which
acted across multiple levels of the SEM (Table 2). Salient
themes are presented by order of importance, determined
by number of studies they were reported in and instances
of overlap within the models.
Stigma
Debilitating experiences with stigma were described in
every study, manifesting as internalized, anticipated and
externalized barriers to progression through all stages of
the cascade. Anticipated stigma (fears surrounding social
exclusion) was common at the individual level, negatively
influencing motivations to obtain an HIV diagnosis [39–46]
and to follow up on test results [44,45]. This was reinforced
by experiences with external stigma at other levels includ-
ing: family neglect or ostracism from peers [39,40,43,47–
50], community gossip [41–43,46], discrimination in school
[49,51–54] or lack of empathy from health care workers
(HCW) [45,50,55–57]. Such social conditions reinforced bar-
riers to HIV care linkage, retention in HIV services and
adherence; with ALHIV often choosing to prioritize secrecy
around their disease status over unintended disclosure
[48,51–55,57–60]. This choice frequently accounted for
missed ART doses when social conditions were unfavour-
able, such as having minimal privacy in the home
[49,51,53,57] or at school [49,52].T
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Figure 3. Map of countries in SSA with published qualitative
research on the ALHIV care cascade.
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Table 2. Themes: First-, second- and third-order constructs and their positioning across the levels of the SEM
3rd order
constructs
2nd order constructs + source papers 1st order constructs + source papers SEM
LEVELS
Care
stages
Stigma n = 23
Anticipated stigma surrounding being
seen utilizing HIV services
(1,2,3,4,5,6,17,20)
“Let me say there is this particular lady who works
at the clinic who is also a neighbour, this lady
might see that particular person going to do a
HIV test and tell the family…” – Strauss, p 7.Anticipation of knowing people at the clinic
(4,6)
Anticipated isolation from peer group
(1,2,4,5)
“…if you are going for an HIV test its going to be
stigmatized that you are sexually active and a
lot of us youngsters do not want people to
think that and know that.” – Ntsepe, p 144.
Anticipated assumptions regarding sexual
activity (2,3,5,21)
Anticipation of unwanted disclosure after
being seen using HIV services (20,24) “My child was pinned a red label on his shirt by
his teacher after he knew the HIV and
treatment status of the child.” – Nyogea, p 7.
I,F,C,S All
Anticipated stigma from family member
(2,3,5,12,14,18)
Enacted stigma from teachers towards
ALHIV (7,12,14,22,23)
Anticipation of disclosure at school by
carrying medication (11,14)
Desire to appear “normal”, avoid enacted
stigma associate with symptoms (14,16)
“Nurses in Soweto do not treat you like human
beings. They stigmatize you and by the time
you leave there you have a different mindset” –
Forrest, p S58.
Enacted stigma from judgemental or
reprimanding HCWs (13,15,18,19,21)
Anticipated stigma prioritizes secrecy
routines over medication adherence
(7,8,9,10,11,12,13,14,16,18,23)
Self-efficacy
surrounding
adaptive
mechanisms
n = 19
Fear of being incapable of making lifestyle
changes (1,2,5,6)
“It isn’t just to go and test, you feel everything,
you never know – because they say a piece of
paper can upset your life.” – Ntsepe, p 143.
I 1, 3, 5
Fears over psychological reactions:
depression, anxiety, suicide, “thinking
too much” (1,2,3,5,6,19) “…for elder children some will show signs of
fatigue with medication. You can hear a child
asking why he must take another dose and he
is not feeling sick.” – Schenk p 24.
Health awareness /knowing ones status
(1,3,4,5,6,11,17,18,22,23)
Frustration surrounding side effects
(9,11,12,14,16,19,21)
Drug fatigue (7,12,14,16,18)
Forgetting (8,12,18)
Frustration surrounding lack of
independence /reactance (9,17,18)
Morning dose problems (oversleeping,
late) (12,18)
Travelling /not being home /school trips
interfere with medication routine
(8,9,11,18)
Pill burden, complicated medication prep
(14,18)
Using alarms & reminder devices
(11,14,18)
“Especially if I am really busy with school or
anything, I set an alarm so I can remember coz
I easily forget to take my drugs.” – Denison p 4.
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Table 2. (Continued)
Concerns over losing family support:
financial or neglect/abuse (1,2,3,5)
“After my father’s death we had a family
meeting, where my family refused to let me
stay with them.” – Midtbo, p 267.
Guardian fails to give consent (3)
HIV+ family members as role models
(3,10,20)
“I had some fear inside: how will my parents
accept it… If only I was above 18 years I could
stand for myself but now I am dependent on
my parents.” Ferrand, p 2327.
Peer or guardian encouragement to test (3)
Empathy from family members (21)
Family support
n = 17
Full, timely disclosure by family
(8,14,17,18,19,22,23)
F 1, 2, 4, 5
Family assisted medication reminders
(7,8,9,10,11,14,18,19,23)
Neglect /orphanhood (8,14,19)
Punishment for adherence slips leads to
dishonesty (16,18)
Skills training, education and support for
caregivers (11,20)
“I: You said if your mother was still around things
would not be happening the way they are now.
Is there anything that you think would be
happening differently..? R: Yes. I: Like what? R:
Like love.” – Peterson, p 972.
HIV counselling offered with no pressure
to test (1,3,4,6)
“Here (at the clinic) they may be talking about
pills, but at the support group children will be
talking about their experiences…” –
Mupambireyi p 109.
Pre- and post-test counselling available (3,6)
Community HIV & SRH educational
available (2,19)
Broader social
support n = 17
ALHIV outreach services /peer support
(19, 23)
C 1, 2, 3, 5
School support /selective disclosure to
“safe” teacher (6,10,14,18,23)
ALHIV community support groups
(8,15,19,21,24)
Sensitization of teachers & school staff (7,22)
Treatment buddies (15,20)
Testing at home /home based care (6,24)
“When I was still in school I used to face cases of
discrimination from other students, which lead
me to tell my teacher to help me.” – Midtbo, p
266.
Youth targeted services & hours
(4,7,9,17,18,21,22,23)
“At the moment, adolescents are being sidelined.
Adults are able to talk for themselves and
children are also represented but no one
represents the adolescents” Mburu, p 15
S 1, 2, 3, 5Adolescent specific
health services
n = 12
Nurses, counselorscounsellors with similar
characteristics to patient (age range,
gender) (2,17)
HCW trained to work with youth /ALHIV
(18,20,24)
HC facilatiesfacilities that offer HIV and
SRH education (17,23)
Clinic co-ordinated disclosure process
with families (17,19)
Full disclosure by HCWs of HIV status and
what ARVs are for (15,23)
“… they are at such a difficult stage in their lives,
to add to that ‘Now you’ve got HIV’, and all the
implications of that, it slays them.” – Cluver, p
S62.
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Table 2. (Continued)
Uninformed about services cost &
location (1,2,3,4,6)
“I would go to a clinic far from home. There are
so many people attending the local clinic who
know me. I wouldn’t want them to know.” –
Francis, p 338.
Uninformed /fearful of what testing
proceedureprocedure entails (1,2,6)
No privacy /confidentiality concerns (4)
“People come and do things so fast because they
want to go back fast – they talk fast, write
drugs, and then say ‘Next’.” – Mburu, p 15.
Adequacy of health
systems n = 12
Appointments take too long (waits
/queues) (1,3,6,21)
ReferedReferred/linked to care following
diagnosis (21,24)
HCWs sensitized to work with HIV+
people (21,24)
Long distance to clinic (2,8)
Support groups /mental health services
offered at the clinic (11,12,14,19)
Understaffed clinics (21)
“At the clinic we try to be as friendly as we can
with adolescents… but sometimes we have a
lot of pressure, especially with adult clients, so
you lose your temper.” – Hodgson, p 1208.
S 1, 2, 3, 5
Long term symptomatic /history of severe
illness prompts testing (3)
“You try and remind them [the child] how they
were … Then they will say ‘I was not going to
school’, ‘I was not able to do this and that’ and
you will ask them if they want to go back to the
same situation.” – Bernays, p 277.
Past illness
narratives n = 10
HCW using reminders of past illness to
motivate ART adherence (17)
Individual’s ART adherence motivated by
fear of becoming sick again
(9,10,11,12,16,19,23)
Motivation to adhere to ART falters after
symptom recovery (9,12,16,18)
“I took the ART for some months and I felt fine, so
I stopped taking them because I felt I was no
longer ill.” – Midtbo, p 265.
I, S 1, 5
Unable to meet indirect costs of care
(travel to clinic, medication for
opportunistic infections)
(2,8,10,15,17,19)
“I wanted to go on my own before I became
seriously ill but I had no money for transport
and to pay at the clinic.” – Ferrand, p 2328.
Financial instability
n = 10
Incentives provided; food, soap, travel
reimbursement, skills training (20)
“Please government, give people [who] have HIV
food. And more money.” – Li, p 755.
F,S 2, 3, 4, 5
Mandatory ART counselling not offered
for free (22)
Household food insecurity limits ART
adherence (8,13,16,19)
“I have a prescription to go and buy drugs [for OI
treatment] for my child but I don’t have the
money. This child needs medication
immediately.” – Schenk, p 21.
Non-full disclosure by guardians about
what medication is for (11,12,13,15,23)
“Then they say I have malaria… so they will give
me medicine… but I cannot start taking the
medicine if I do not know where I got the
malaria from.” – Mupambireyi, p 109.Social coping
mechanisms
n = 9
Assigning reasons for taking medication to
alternate illness to prevent unintended
disclosure (7,11,14,19,22)
“… my friends don’t know that I had the virus [so I
said] I felt some malaria.” – Denison, p 2.
I,F 5
Family goals /women planning pregnancy
(1,3,4)
Goals (family, career or education)
facilitates linkage & retention in HIV
care (10,19,23)
“As a mother, I need to be healthy for the sake of
my child. I want to set an example by making
good decisions.” – Francis, p 336.
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Self-efficacy to adapt to a life with HIV
Adolescents understood that the event of receiving an
HIV positive diagnosis would require them to make life-
style changes that, in many instances, they lacked con-
fidence to adopt. Fear surrounding the ability to manage
the consequences of a positive diagnosis frequently cre-
ated a barrier to testing [39,40,42,43,47]. Such dimin-
ished self-efficacy similarly affected ALHIVs’ capacity to
maintain new health behaviours over time, such as the
ART adherence necessary to achieve viral suppression,
due to frustration surrounding the ongoing nature of
treatment or side effects [48–53,57,58,60,61]. Lack of
self-efficacy was often associated with an absence of
empathetic support to adolescents offered within HIV
services regarding how to integrate these required new
behaviours into their lifestyles [45,49–53,57,58,60]. Self-
efficacy was restored through acts or interventions that
operated at other levels of the SEM including support
from family members, participation in community sup-
port groups or support from treatment buddies [48–
52,54,57–59].
Family support
The presence or absence of family support strongly influ-
enced adolescents’ testing, linkage to care, and adherence
to ART. Definitions of “family” were broad, and could
include biological parents, distant relatives, close friends
and /or other caregivers. “Support” was defined as empa-
thy, encouragement or care provided during sickness
[52,57], having an HIV-positive role model [47,59] and
assistance with medication reminders [48–52,54,57–59].
Lack of family support included non-full disclosure to
ALHIV of their status [46,48–50,54,57,61], neglect or
abuse [48–50] and failure to provide consent for services
[47], all of which negatively influenced movement through
the care cascade.
Broader social support
The inclusion of social services in communities was cited as
facilitating engagement at all stages of the HIV care cas-
cade. ALHIV support groups [44,45,48,54,56], home-based
care [43,62] and HIV /sexual and reproductive health edu-
cation through school or outreach programmes
[40,45,50,54] were all detailed as beneficial resources.
The presence or lack of support within schools in particular
was influential in terms of ART adherence, experiences with
discrimination from other students or teachers negatively
influenced the ability of ALHIV to carry medication and
manage a dosing schedule at school [49,51,53,54], and
crowded environments with no privacy, particularly in
boarding schools, exacerbated fears surrounding unin-
tended disclosure [49,52,57,58]. However, when selective
disclosure to a “safe” teacher or school nurse was obtained,
it frequently facilitated good adherence to ART
[49,51,54,59].
Adolescent-specific health services
ALHIV often faced difficulties in transitioning between pae-
diatric and adult models of care; several studies reported
that health services which catered specifically to
Table 2. (Continued)
Future orientation
n = 9
Perception of having “no future”
following diagnosis as a barrier to
testing and care enrollmentenrolment
(2,4,10,20)
Family, education or life goals as ART
adherence motivators (10,12)
“I am scared because I want to finish school and
you know, get a job and have a boyfriend, but I
don’t know how to do that as a person with
HIV.” – Li, p 755.
I 1, 2, 5
Media influence
n = 7
Media influenced adolescents HIV
knowledge /“Know Your Status”
campaign (1,2,3,4,5,6)
“I would go for VCT because it’s importland to
know my status. It will help me stay protected
and also protect others.” – Francis, p 336.
C 1, 2
Media campaigns to reduce HIV service
stigma (2,22)
Traditional medicine used to avoid costs
of care (7)
Reliance on
traditional
medicine n = 5
Caregiver decision to treat with TM
(12,13)
TM practicionerspractitioners claiming to
heal HIV (7,11,18)
Medication mythology /mistrust of ART
(12,18)
“I used those herbs and I have even drunk urine
because there is someone who came and lied
to us that drinking urine can heal HIV.” –
Kunapareddy, p 391.
F,C 1, 2, 5
SEM levels: I – Individual; F – Family /Peer; C – Community; S – Structural.
Cascade stages: 1 – diagnosis; 2 – linkage to care; 3 – engagement /retention in care; 4 – ART initiation and adherence; 5 – viral suppression.
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adolescents’ needs positively influenced their progression
through the cascade. Services which accommodated
“youth-friendly” hours that didn’t interfere with school or
work were often cited as facilitating access to HIV testing,
pre-ART care and ART [41,45,46,51,57,58,61], as were
HCWs who had undergone specific training to work with
adolescents [44–46,57,62]. In addition, adolescents
expressed a preference for HIV counsellors who shared
similar characteristics to themselves (age range or gender)
to avoid feeling that counselling messages were condes-
cending [40,46]. Sexual and reproductive health education
incorporated into health services [46] and HCW participa-
tion in the disclosure processes [46,50,54,56] were found to
positively influence both ALHIV retention in care and
adherence.
Adequacy of health systems
Adolescents’ linkage to and retention in care were affected
by the ability of the health system to provide efficient,
confidential and comfortable services. This included the
presence or absence of outreach efforts to inform ALHIV
about service availability [39–41,43,47], pre- and post-test
counselling options [39,41,43,47] and employment of suffi-
cient numbers of HCW of various cadre [39,43,45,47]. The
infrastructural capacity to avail space within health facilities
to ensure privacy [45,62] and the total time required for
appointments based on queues and travel to and from the
clinic further compounded barriers to both HIV diagnosis
and retention in care [39,40,43,45,47,48].
Past illness narratives
Experiences with physical deterioration and severe illness
could often facilitate engagement in HIV care, specifically in
regard to receiving an HIV diagnosis [47] and adhering to
treatment [50,52–54,58–60]. Within families and at health
facilities, these past illness narratives were used as remin-
ders by caregivers and HCWs to facilitate ALHIV’s adher-
ence to ART [46,60]. Conversely, experiencing
improvements in symptoms could also hinder adolescents’
ART adherence, particularly if their HIV status had not been
fully disclosed to them, or they had limited knowledge
about their illness and its treatment requirements: several
studies identified faltering adherence among ALHIV who
had regained physical strength and a “normal” appearance
[51,53,57,58,60].
Financial instability
The direct and indirect costs of care and treatment acted as
a barrier to HIV care engagement, demonstrated at the
family and structural level of the SEM. The cost of trans-
portation to reach appointments [40,46,48,55,56,59] or
additional food required to satisfy the nutritional needs of
adolescents on ART [48,50,55,60] negatively influenced
family willingness or ability to support ALHIV. At the struc-
tural level, the absence of available financial assistance to
cover the costs of medications for opportunistic infections
or ART counselling exacerbated the situation [50,60,61].
Conversely, one study found that the inclusion of economic
incentives including food, household provisions or travel
reimbursement encouraged linkage to care among
ALHIV [44].
Social coping mechanisms
In multiple studies, adolescents described a variety of cop-
ing mechanisms to navigate social situations that threa-
tened unwanted disclosure. Such strategies included
ALHIV claiming that their drugs, AIDS symptoms or pro-
longed school absences were the result of an alternate
condition, such as heart problems or malaria [49,50,52–
56,61]. These strategies were also used by caregivers and
HCWs to avoid disclosure to younger ALHIV of their true
condition at the family and structural SEM levels
[51,54,57,58]. Such tactics were utilized to facilitate short-
term ART adherence, despite their apparently limited effec-
tiveness to help ALHIV achieve sustained adherence to
treatment.
Future orientation
Future aspirations, and the ability to identify personal goals
including marriage, pregnancy or further education were
cited in several studies as factors that motivated ALHIV to
obtain an HIV diagnosis [39,41,47], to link to HIV care [58]
and to adherence to their antiretroviral therapy [53,59].
However, adolescents’ fear of having diminished options
in the future following a positive HIV diagnosis acted as a
barrier to diagnosis and ART adherence [40,41,44,59]
Media influence
Mass media campaigns were identified as effective in pro-
moting knowledge surrounding HIV risk factors and diag-
nosis. The HIV testing campaign slogan ALHIV repeatedly
referenced was the “Know Your Status” (KYS) campaign,
that originated in Lesotho [63]. The “KYS” slogan and asso-
ciated statements regarding the moral imperative of testing
were recited by adolescents in multiple countries during
interviews [39,41–43,47]. However, researchers noted that
despite this familiarity with the KYS campaign, rates of
testing often remained low [40,41]. Media campaigns
were also detailed as a means of counteracting community
stigma towards ALHIV that undermined HIV service enrol-
ment [40,61].
Reliance on traditional medicine
The use of traditional medicine was identified in the SEM at
the family and community levels as a barrier to linkage to
HIV care and to ART adherence. Reliance on traditional
medicine for health care delayed the initiation of ART
[52,57,60], and was favoured at times by caregivers
[53,55] with reduced costs cited as justification for their
use by economically strained families [60]. Lack of commu-
nity HIV and ART education also contributed to the perpe-
tuation of local disease mythologies associated with the use
of traditional medicine to treat HIV [57,60].
Discussion
Our meta-ethnographic approach to the analysis of qualita-
tive literature published across varying contexts in SSA
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revealed striking thematic similarities across different coun-
tries and over time. Stigma, family support, self-efficacy
and social support were common themes resonating across
multiple settings in SSA and across the 10-year period of
inquiry. The degree of consistency in these findings across
diverse settings suggests that similar interventions to
improve the uptake of HIV care among ALHIV may be
relevant in many SSA countries.
Out of 24 selected articles, only seven investigated multi-
ple stages of the HIV care cascade. Most of the studies
focused on discreet aspects of HIV care and treatment, in
particular testing or adherence, leaving stages such as link-
age to care and initiation onto treatment under-repre-
sented. In order to better understand the impacts of
efforts being made to achieve the UNAIDS 90-90-90 targets
[64], further investigation of the full spectrum of ALHIV
experiences with HIV care is needed.
During the time-period evaluated, the most significant
efforts to promote HIV engagement have primarily acted
at the structural level: for example, free ART provision,
expansion of counselling and testing services and formation
of support groups in many clinics. However, it was the
threat of social isolation as a result of attitudes towards
HIV that emerged as the most influential factor hindering
ALHIV progression through all stages of the care cascade.
Detrimental experiences with stigma were the most salient
theme across the entire time-span, suggesting that struc-
tural-level interventions have had limited impact on indivi-
dual experiences of living with HIV over the last 10 years.
Given that structural interventions alone are unlikely to
act at multiple levels of the SEM, the potential of youth-
specific services to improve rates of care retention in SSA (a
facilitator to HIV care engagement detailed in numerous
articles) is ultimately reliant on the presence of mutually
improved conditions at the other SEM levels [65]. Their
ability to facilitate the movement of ALHIV through the
stages of the care cascade is contingent upon caregiver
support, community perceptions of services, and experi-
ences of stigma associated with their use. Further, training
new or existing HCWs to work with adolescents, expanding
services to youth-friendly hours and improving upon the
efficiency of appointments all require a sustained and sub-
stantial economic commitment [66] which is in turn depen-
dent on international funding priorities and domestic health
policies [67–70].
We noted that stigma was commonly anticipated by
ALHIV, often manifest through fear of unwanted disclosure
of their positive status after being seen using HIV services
or taking medication. These individual level fears pervaded
into other SEM levels, where they threatened to deterio-
rate relationships with loved ones or result in ostracism by
the community. The power of such anticipated stigma to
negatively affect adolescent care engagement in SSA can-
not be overstated, particularly as it compounds the hard-
ships that many ALHIV have already gone through following
early parental loss and learning their own positive HIV
status. This appears distinct from the dominant manifesta-
tions of stigma amongst adults living with HIV in SSA
[71,72]. The stigma experienced by many adults living
with HIV is inextricably linked to blame or promiscuity
[51,73]. Witnessing such enacted stigma demonstrated
towards adults may not only reinforce anticipated stigma
in ALHIV at the individual level, but also presents a barrier
to their care at other levels of the SEM where they require
the support of adults. For example, guardian experiences’
with enacted stigma may result in failure to provide ALHIV
with the consent and accompaniment required to access
HIV care in some areas, out of their own unwillingness to
be seen utilizing HIV services [51,74,75]. Our findings sug-
gest that interventions to address stigma need to account
for the inherent differences between ALHIV and adults
living with HIV. Care should be taken to not assume that
the same forces driving stigma amongst an adult population
resonate amongst adolescents.
In the absence of coordinated support to address treat-
ment challenges among ALHIV, motivational techniques
were often applied by caregivers or HCWs, such as the
use of past illness narratives to facilitate ART adherence
based on ALHIVs’ desires to maintain “normalcy”
[49,53,57,58,60]. Our meta-ethnography highlights that
HCW used the motivation of “staying well” to encourage
adherence, insinuating a comparison to a past period of
ill health. Further, both ALHIV and their caregivers
reported inventing an alternate illness to attribute medi-
cation use to, either to avoid disclosure from caregiver to
ALHIV or from ALHIV to the wider community of
extended family, peers and teachers. The use of past or
alternative illness narratives represent makeshift
approaches to adherence and disclosure that have been
utilized in the absence of broader social support to help
ALHIV manage care dilemmas attached to stigma. Recent
changes in guidance for ART eligibility to include all who
test HIV positive regardless of their immune status or
WHO staging [69,76] should reduce the occurrence of
“past illnesses” and could therefore change how ALHIV
engage with HIV care. Social approaches to managing
engagement in HIV care and adherence should encourage
early and ongoing disclosure assisted by HCWs, rather
than being left to the responsibility of families alone
[30,77–79]. This coordinated disclosure will need to
place greater emphasis on sustainable facilitators to self-
efficacy, such as future orientation, to avoid use of short-
term tactics that fail to recognize the capacity of ALHIV to
understand and manage their illness.
The self-efficacy of ALHIV is recognized as a key facilitator
to diagnosis, retention in care and adherence to ART.
However, its effect is reliant on social conditions such as family
environment, presence or absence of peer support and the
attitudes of HCWsworking with youth. Inclusion of supportive
social conditions at different levels of the SEM, such as com-
munity support groups, family counselling and HIV /sexual
and reproductive health education, has the potential to bol-
ster self-efficacy and motivate ALHIV through the stages of
care [80–83]. In the absence of supportive conditions, ALHIV
self-efficacy may fail to develop or result in rebellion against
their care management [84] as they gain further indepen-
dence with age, yet maintain a sense of social isolation and
frustration surrounding treatment adaptation.
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We concur with others that have taken a critical stance on
the utility of a linear model of the HIV care cascade with a
proposed end-point of viral suppression [85]. Our systematic
review of evidence suggests that such a model is not sufficient
to generalize the ongoing and evolving process of managing a
lifelong condition for ALHIV. In Figure 4, we illustrate how the
reality is a succession of ebbs and flows as ALHIV attempt to
“scale a waterfall” to achieve viral suppression. Ethnographic
and qualitative descriptions portray movement which requires
upward momentum to move through these stages, with
ALHIV using facilitators as footholds to manoeuvre against a
downward cascade of barriers that persistently threaten to
undermine their intentions to engage in HIV care.
Our study is affected by various limitations inherent to
qualitative studies and the meta-ethnography design.
Adolescents may be prone to social desirability bias in
their responses, particularly when discussing behaviours
such as ART adherence or clinic attendance. In addition,
most of the studies in our analysis adopted a cross-sec-
tional rather than a longitudinal design, which may have
been better suited to identify issues related to transition
between paediatric and adult models of HIV care. Our
search was limited to publications in English which may
partially explain the geographic gaps in the research
studies that we identified; however, these gaps may
also be influenced by differences in research funding
across countries. Although our search criteria were
broad, some relevant studies may not have been cap-
tured by our choice of terms; yet this risk should be
minimized by our strategy of searching through the refer-
ence lists of relevant articles. Furthermore, due to limited
available research exploring gendered differences in ado-
lescent HIV care, our ability to unpick gender-specific
factors influencing cascade progression was limited.
Additional qualitative research should be undertaken to
explore the risk perceptions, knowledge of HIV transmis-
sion, sources of SRH education and experiences of ado-
lescent females with HIV services, not only because they
are at higher risk of acquiring HIV [6,64,86,87], but also
because their experiences with stigma may profoundly
reinforce barriers to testing or ART for PMTCT [80,88,89].
To our knowledge, this is the first meta-ethnography of
research on factors influencing engagement in HIV care
among adolescents in SSA that examines treatment progres-
sion holistically, by synthesizing studies focused on different
aspects of the care cascade. Our use of a socio-ecological
lens provides a comprehensive view of the issues influencing
HIV care engagement, and enables us to analyse the inter-
play between individual, family, community and structural
factors. The findings generated through this review are
timely given the current focus on adolescent health within
global health initiatives and also since the adolescent HIV
epidemic in the region has peaked, and readiness to test,
commence treatment and adhere successfully to ART is
essential in reducing transmission rates and preventing
drug resistance [77]. Significant efforts are still required to
ensure that this important age group do not fall further
behind in the global effort to eradicate AIDS by 2030 [90].
Conclusions
For ALHIV in SSA, individual-level issues are the most influ-
ential in preventing engagement across all stages of the HIV
care cascade, although family, community and structural
issues also play an important role. Despite scale-up of
services and increased availability of ART in SSA over the
past decade, stigma remains the most pervasive barrier to
HIV care engagement, present at each level of the SEM, and
Figure 4. “Scaling a waterfall”: upward momentum among ALHIV through the HIV care cascade stages.
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hindering progression across all stages of the care cascade.
Psychosocial interventions among adolescents and their
families should be prioritized to improve adolescents’
engagement in HIV care, enhance their wellbeing and ulti-
mately reduce their risk of ill-health and mortality.
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